Flu attacks are common and they take a toll on your immunity. It allows the virus to invade your body and damage the healthy cells. The treatment mostly depends on how well your body is able to fight back. Health experts often suggest that you must get yourself injected with Influenza vaccines, more commonly known as flu shots or jabs, that provide protection against the influenza viruses. These vaccines help your body develop antibodies about two weeks after vaccination that protect you against infection with the viruses. A group of researchers from the Georgia Institute of Technology and Emory University, are now working on creating a pain-less patch that can help people self-administer the vaccine with the press of a thumb.
As of today, these vaccines are injected with the help of needles and they need to be taken yearly as they tend to become ineffective. According to this new study, published in the renowned journal The Lancet, the whole process can be made much simpler with a flu patch. The study reveals details about the first clinical trial of the flu jab patch conducted by the researchers.
For trial, 100 people were divided into four groups. The first group received the patch from a healthcare professional, the second group used it one their own, the third group were injected with traditional shots and the last group was given the patch with a placebo. The study concluded that
providing vaccination using these patches resulted in robust immunologic responses whether administered by health care workers or by the participants themselves. These micro-needle patches are low-priced, durable and can be easily stored. Researchers believe that they can be effective alternatives to the traditional influenza vaccines.
The phase one of the FDA trial has regards the flu patch as safe but with some minor side effects. More trial will be conducted over the year before deciding to release them for public use.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022